Barry A. Schechter, MD

The decision of which type of IOL to implant in a patient is a multistep process in my practice.

Topical ophthalmic nonsteroidal anti-inflammatory drugs can be used for the prevention of intraoperative miosis, the treatment of ocular allergy, the relief of pain from corneal surgery and/or trauma, the reduction of inflammation and photophobia following cataract surgery, and the prevention and treatment of postoperative cystoid macular edema. Because studies evaluating additional therapeutic uses for these agents are sparse ophthalmologists may extrapolate data and consider case presentations.